457 related articles for article (PubMed ID: 22019891)
1. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome.
Wei W; Zhao H; Wang A; Sui M; Liang K; Deng H; Ma Y; Zhang Y; Zhang H; Guan Y
Eur J Endocrinol; 2012 Jan; 166(1):99-105. PubMed ID: 22019891
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
3. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
Ye BL; Yang HY; Zhao JZ; Lin JJ; Lin WQ
Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):745-8. PubMed ID: 14728846
[TBL] [Abstract][Full Text] [Related]
4. Effects and plasma proteomic analysis of GLP-1RA versus CPA/EE, in combination with metformin, on overweight PCOS women: a randomized controlled trial.
Liao M; Li X; Zhang H; Zhou L; Shi L; Li W; Shen R; Peng G; Zhao H; Shao J; Wang X; Sun Z; Zheng H; Long M
Endocrine; 2024 Jan; 83(1):227-241. PubMed ID: 37653215
[TBL] [Abstract][Full Text] [Related]
5. Effect and mechanism of berberine against polycystic ovary syndrome.
Zhang SW; Zhou J; Gober HJ; Leung WT; Wang L
Biomed Pharmacother; 2021 Jun; 138():111468. PubMed ID: 33740526
[TBL] [Abstract][Full Text] [Related]
6. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
[TBL] [Abstract][Full Text] [Related]
7. Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study.
Mishra N; Verma R; Jadaun P
Cureus; 2022 Jan; 14(1):e21781. PubMed ID: 35251851
[TBL] [Abstract][Full Text] [Related]
8. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR
Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of abdominal acupuncture for patients with obesity-type polycystic ovary syndrome: a randomized controlled trial.
Zheng YH; Wang XH; Lai MH; Yao H; Liu H; Ma HX
J Altern Complement Med; 2013 Sep; 19(9):740-5. PubMed ID: 23676106
[TBL] [Abstract][Full Text] [Related]
10. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
11. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
12. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment.
Heutling D; Schulz H; Nickel I; Kleinstein J; Kaltwasser P; Westphal S; Mittermayer F; Wolzt M; Krzyzanowska K; Randeva H; Schernthaner G; Lehnert H
J Clin Endocrinol Metab; 2008 Jan; 93(1):82-90. PubMed ID: 17986642
[TBL] [Abstract][Full Text] [Related]
13. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment.
An Y; Sun Z; Zhang Y; Liu B; Guan Y; Lu M
Clin Endocrinol (Oxf); 2014 Mar; 80(3):425-31. PubMed ID: 23869585
[TBL] [Abstract][Full Text] [Related]
14. Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.
Sam S; Scoccia B; Yalamanchi S; Mazzone T
Hum Reprod; 2015 Jun; 30(6):1358-64. PubMed ID: 25857311
[TBL] [Abstract][Full Text] [Related]
15. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study.
Trolle B; Lauszus FF; Frystyk J; Flyvbjerg A
Fertil Steril; 2010 Nov; 94(6):2234-8. PubMed ID: 20189560
[TBL] [Abstract][Full Text] [Related]
17. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
Tan S; Hahn S; Benson S; Dietz T; Lahner H; Moeller LC; Schmidt M; Elsenbruch S; Kimmig R; Mann K; Janssen OE
Eur J Endocrinol; 2007 Nov; 157(5):669-76. PubMed ID: 17984248
[TBL] [Abstract][Full Text] [Related]
18. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.
Pasquali R; Gambineri A; Anconetani B; Vicennati V; Colitta D; Caramelli E; Casimirri F; Morselli-Labate AM
Clin Endocrinol (Oxf); 1999 Apr; 50(4):517-27. PubMed ID: 10468913
[TBL] [Abstract][Full Text] [Related]
19. The effect of alfacalcidiol and metformin on metabolic disturbances in women with polycystic ovary syndrome.
Figurová J; Dravecká I; Petríková J; Javorský M; Lazúrová I
Horm Mol Biol Clin Investig; 2017 Mar; 29(3):85-91. PubMed ID: 28157691
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
Zhao H; Xing C; Zhang J; He B
Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
